Heart Failure

Adults with diabetes with cardiomyopathy were at significantly higher risk for developing incident HF, according to new data published in the Journal of the American College of Cardiology.

The American Heart Association announced it is launching the Home Health Heart Failure Certification Program for home health agencies that provide care for patients with HF.

Recognizing the signs and symptoms of HF at any stage, as outlined in the updated universal definition of HF, is crucial to the timely application of optimal guideline-recommended medical therapy, a speaker reported.

Mobile health intervention to improve physical activity, quality of life and metabolomic profiles in patients with HF and diabetes.

Aficamten (Cytokinetics) in patients with hypertrophic cardiomyopathy and elevated LV outflow tract.

Dapagliflozin (Farxiga, AstraZeneca) vs. placebo for improvements in symptoms and physical limitations in HF with preserved ejection fraction.

Compared with just a few years ago, medical treatment options for HF with preserved ejection fraction have expanded greatly, culminating in the first useful new agent for the HFpEF population.

The incidence of Chagas cardiomyopathy in the U.S. increased from 2002 to 2017, particularly among individuals who emigrated from Central and South America, and was associated with risk for arrhythmia and HF, researchers reported.

A novel risk calculator leveraging two widely available clinical biomarkers can accurately predict heart failure hospitalization for adults with type 2 diabetes at high atherosclerotic cardiovascular disease risk, data show.

Long-term exposure to fine particulate matter, nitrogen dioxide and noisy road traffic may induce risk factors associated with disease progression of HF, according to research published in the Journal of the American Heart Association.